Kiora PharmaceuticalsKPRX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 17 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, up 1 from Q2 2025. 5 opened new positions and 4 sold out. The largest holders were ADAR1 Capital Management, LLC ($467K), Nantahala Capital Management, LLC ($435K) and Stonepine Capital Management, LLC ($391K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $354K |
| Exits | 4 | $976K |
All 13F filers, Q2 2025 → Q3 2025: 131,700 shares bought and 447,374 shares sold, net −315,674 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| ADAR1 Capital Management, LLC | 0.05% | Add +0.5% | 167,941 | $467K |
| Nantahala Capital Management, LLC | 0.03% | Reduce -25.9% | 156,427 | $435K |
| Stonepine Capital Management, LLC | 0.32% | Reduce -21.0% | 140,598 | $391K |
| Citadel Advisors | 0.00% | New | 44,573 | $125K |
| DRW Securities, LLC | 0.01% | New | 36,865 | $102K |
| Vanguard Group Inc. | 0.00% | New | 20,915 | $59K |
| Geode Capital Management, LLC | 0.00% | Add +1.5% | 18,853 | $53K |
| Renaissance Technologies | 0.00% | New | 12,400 | $34K |
| Two Sigma Investments, LP | 0.00% | New | 11,984 | $33K |
| Citigroup Inc. | 0.00% | Add +10997.1% | 3,884 | $11K |
| UBS Group AG | 0.00% | Reduce -92.3% | 1,364 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 256 | $712 |
| BlackRock, Inc. | 0.00% | No change | 58 | $161 |
| Bank of America Corp. | 0.00% | Add +19.1% | 25 | $70 |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $61 |
| Activest Wealth Management | 0.00% | No change | 2 | $6 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $5 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.